Current Treatment for Shingles (Herpes Zoster)
Start oral antiviral therapy within 72 hours of rash onset with acyclovir, valacyclovir, famciclovir, or brivudin (where available), as early treatment significantly reduces acute pain, accelerates healing, and may decrease the risk of postherpetic neuralgia.
Antiviral Therapy
First-Line Oral Antivirals
The cornerstone of shingles treatment is systemic antiviral medication, which should be initiated as soon as possible, ideally within 72 hours of rash appearance 1, 2. The following agents have equivalent efficacy and safety profiles:
- Acyclovir: 800 mg orally 5 times daily for 7-10 days 1, 2
- Valacyclovir: 1 g orally 3 times daily for 7 days 1, 2
- Famciclovir: 500 mg orally 3 times daily for 7 days 1, 2
- Brivudin (where available): 125 mg orally once daily for 7 days 2
Valacyclovir and famciclovir offer improved oral bioavailability compared to acyclovir, allowing for less frequent dosing and potentially better patient adherence 1. Brivudin has markedly higher anti-VZV potency and requires only once-daily dosing, with no nephrotoxic properties 2.
Urgent Indications for Antiviral Therapy
Systemic antiviral treatment is urgently indicated in the following situations 2:
- All patients ≥50 years of age
- Herpes zoster involving the head and neck area (especially zoster ophthalmicus)
- Severe herpes zoster on trunk or extremities
- Immunocompromised patients at any age
- Patients with severe atopic dermatitis or eczema
Intravenous Therapy
For severe disease requiring hospitalization (disseminated infection, encephalitis, pneumonitis, hepatitis, or acyclovir-resistant strains in immunocompromised patients), use acyclovir 5-10 mg/kg IV every 8 hours for 5-7 days 3.
Pain Management
The primary goal of herpes zoster treatment is achieving painlessness 2. Pain management should be initiated concurrently with antiviral therapy:
Acute Pain Control
- Appropriately dosed analgesics combined with a neuroactive agent (e.g., amitriptyline) are highly effective when given with antiviral therapy 2
- Corticosteroids may shorten the duration and severity of acute zoster pain, though they have minimal effect on preventing postherpetic neuralgia 2
Postherpetic Neuralgia (PHN) Treatment
For pain persisting ≥90 days after acute herpes zoster 4:
- Topical agents: Lidocaine or capsaicin 4
- Oral medications: Gabapentin, pregabalin, or tricyclic antidepressants 4, 5
- Note that PHN treatment often provides poor relief, with up to half of patients achieving less than 50% pain reduction 6
Special Populations
Immunocompromised Patients
- May require higher doses of antivirals (e.g., acyclovir 400 mg orally 3-5 times daily) 3
- Prolonged treatment courses may be necessary 3
- For acyclovir-resistant strains: foscarnet 40 mg/kg IV every 8 hours or topical cidofovir gel 1% daily for 5 days 3
- HIV-infected patients should be monitored closely, as healing may be slower and treatment failures can occur 3
Pregnancy
- Oral acyclovir can be used for first clinical episodes during pregnancy 3
- IV acyclovir is indicated for life-threatening maternal HSV infection (disseminated infection, encephalitis, pneumonitis, hepatitis) 3
- Current registry findings do not indicate increased risk for major birth defects with acyclovir treatment 3
Important Clinical Considerations
Timing is Critical
Peak viral titers occur within the first 24 hours after lesion onset 3. Since the natural healing process begins within this timeframe, treatment must be initiated as early as possible to ensure optimal therapeutic benefit 3.
Topical Therapy
Avoid topical acyclovir as it is substantially less effective than systemic therapy 3. Topical antivirals are not effective prophylactically because they cannot reach the site of viral reactivation in the dorsal root ganglia 3.
Prevention
For patients ≥50 years old, vaccination is the most effective preventive measure 4. The recombinant zoster vaccine (RZV/Shingrix) is preferred over the live attenuated vaccine (ZVL/Zostavax) due to superior efficacy and durability 3, 7.